|
|
Article: Pfizer Receives Approval From European Commission For Pending Acquisition Of Wyeth.
- Article from:
- Business Wire
- Article date:
- July 17, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Provides Update on Regulatory Submission in China
European Commission Approval Includes Certain Commitments
NEW YORK -- Pfizer Inc (NYSE: PFE) today announced that the European Commission (EC) has approved under the European Union (EU) Merger Regulation the company's pending acquisition of Wyeth. The Commission's decision includes Pfizer's commitment to divest certain animal health assets in the EU.
"We are pleased to have achieved another significant milestone for the pending acquisition with the EC's approval of the transaction," said Amy Schulman, senior vice president and general counsel of Pfizer.
In addition, Pfizer announced ...